Skip to main content
OpenTrials
Completed

NCT Number: NCT05458206

Effect of Mulligan Snag and Diaphragmatic Release on Thoracic Kyphosis

the aim of this study is to investigate the efficacy of mulligan snag mobilisation and diaphragmatic release on upper crossed syndrome

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postural Kyphosis, Cervicothoracic Region

Age range

17 year–22 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of physical therapy, Cairo, Giza Governorate, Egypt

Loading trial locations.

About this study

Acquired postural disorders can be a consequence, to a large extent, of contemporary living and working conditions. Some of the most typical factors include continuous use of mobile phones and computers, working in sedentary jobs. Prolonged incorrect posture and reduced physical activity present a dis-balance in the musculature . It can also lead to vision issues, as well as headaches, musculoskeletal issues, and pain, as well as a multitude of other symptoms.

Upon the available research studies, there is not study conducted to investigate the effect of mulligan SNAG mobilization and diaphragmatic release in upper crossed syndrome patients this trial has four groups; one will receive diaphragmatic release + conventional, the second will receive mulligan SNAG mobilization, and conventional, the third will receive mulligan SNAG mobilization+diaphragmatic release+conventional, the fourth subjects will receive conventional

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ranged from 17 to 22 years .
  • Body Mass Index from 20 to 25 kg/m² .
  • All participants have an intensity of neck pain on VAS (4-8) (moderate cases) .
  • The subjects were chosen from both sexes.
  • All participants have kyphosis angle ≥42°
  • All participants have mechanical neck pain and FHP (craniovertebral angle CVA < 49) CVA of < 49) .

Exclusion criteria

  • Malignancy
  • Fractures of the cervical spine
  • Cervical radiculopathy or myelopathy
  • Vascular syndromes such as vertebrobasilar insufficiency
  • Rheumatoid arthritis
  • Neck or upper back surgery
  • Taking anticoagulants
  • Local infection
  • Whiplash injury

Treatment and study plan

mulligan snag mobilization and diaphragmatic release

Other

The patients will be in the supine position. The therapist makes manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th ). During the patient's inspiration, the therapist will gently pull the points of hand contacts toward the head and slightly laterally. During exhalation, the therapist will deepen hand contact toward the inner coastal margins.

mulligan snag, Apply a passive intervertebral movement in a superior anterior direction along the facet plane. While maintaining this "glide" as the patient actively moves in any range of physiological movement

Primary outcomes

  1. pain intensity

    Time frame: up to four weeks

    The scale that will be used is the Visual analogue scale;each subject will be instructed to put point on a line from no pain to tolerable pain

Secondary outcomes

  1. cervical range of motion

    Time frame: up to four weeks

    theCROM device will placed on patient's head while he/she seated and looking forward the difference between the ponter value and the value after movement will be recorded as the motion angle of the cervical vertebrae

Other outcomes

  1. forward head

    Time frame: up to four weeks

    the craniovertebral angle (CVA) (the angle between the horizontal lines passing through and a line extending from the tragus of the ear to C7 notably). Lesser CVA indicates greater FHP

  2. kyphotic angle

    Time frame: up to four weeks

    the bubble inclinometer is gravity-dependent, it is first zeroed on a vertical wall prior to measurement. Using a standard clinical procedure. the cephalic foot of the inclinometer will be placed on the pencil mark already on the C7 spinous process. This procedure will be repeated for the lower thoracic spine, with the caudal foot of the inclinometer placed on the pencil mark for T12. Both inclinometer angles will be recorded, taking care to minimize parallax error with each measurement by ensuring the recorder's eyes are on the same horizontal plane as the inclinometer. The thoracic kyphosis measure from the inclinometer readings will be obtained by taking the difference between the two measurements.

  3. chest expansion

    Time frame: up to four weeks

    Measurements will be taken with the participants in a standing position with their arms along the body. The physiotherapist placed the "0" of the cloth tape measure on the appropriate vertebrae. The cloth tape will be held with an index finger between the participant's body and the cloth tape, without generating any deformation or cutaneous folds. The inspiratory diameter will be subtracted from the expiratory diameter to calculate the CE value.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jul 14, 2022
Registry last updated
Jul 25, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.